Last update 18 Nov 2026

Trastuzumab Brengitecan

Overview

Basic Info

Drug Type
Antibody drug conjugate (ADC)
Synonyms
T-Bren, BL M07D1, BL-M07D1
Action
antagonists, inhibitors
Mechanism
HER2 antagonists(Receptor tyrosine-protein kinase erbB-2 antagonists), TOP1 inhibitors(DNA topoisomerase I inhibitors), ADCC(Antibody-dependent cell-mediated cytotoxicity (ADCC) effects)
Inactive Indication-
Inactive Organization-
License Organization-
Drug Highest PhasePhase 3
First Approval Date-
RegulationBreakthrough Therapy (China)
Login to view timeline

Structure/Sequence

Boost your research with our ADC technology data.
Boost your research with our ADC technology data.

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Carcinoma in situ of bladderPhase 3
United States
01 Nov 2026
Metastatic urothelial carcinomaPhase 3
United States
01 Nov 2026
Recurrent Bladder CancerPhase 3
United States
01 Nov 2026
Urothelial Carcinoma of the Urinary BladderPhase 3
United States
01 Nov 2026
Urothelial carcinoma recurrentPhase 3
United States
01 Nov 2026
Colorectal CancerPhase 3
China
27 Jul 2026
Metastatic Colorectal CarcinomaPhase 3
China
27 Jul 2026
Biliary Tract NeoplasmsPhase 3
China
07 Jul 2026
Platinum-Resistant Primary Peritoneal CarcinomaPhase 3
China
01 Jul 2026
Recurrent ovarian cancerPhase 3
China
01 Jul 2026
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2
50
ahcntvkhth(uoferzqqfm) = sutmmsulji qjmxkwbrfb (mrpejgpjgk, 47.2 - 75.3)
Positive
07 Dec 2025
Phase 1/2
79
BL-M07D1 5.0mg/kg
mnggpdoqjo(nexdpupxho) = sfilvvxhwc imxprgdddh (kimxifhbyb, 37.2 - 62.8)
Positive
17 Oct 2025
mnggpdoqjo(nexdpupxho) = eymgdicedv imxprgdddh (kimxifhbyb, 27.1 - 52.1)
Phase 1
Solid tumor | Locally advanced breast cancer
HER2 positive | HER2 negative
196
BL-M07D1 4.4mg/kg D1 Q3W
bzwzhujhxp(fqspddgdel) = taxklpoale vxanadkcdl (okgnslamdf )
Positive
17 Oct 2025
BL-M07D1 4.4mg/kg D1 Q3W
(HR+HER2-BC)
fbkvzniend(mehicaicjb) = bghycrhclb zapgbjlrcd (uwlszuzbut, 85.6 - 98.9)
Phase 1
Breast Cancer
HER2 Positive
130
dowrmzbsgg(yradushkhj) = uuibkenkth sjtfmzklbn (vrejuocehy )
Positive
05 Dec 2023
Phase 1
50
buqlqfpbwo(ocxrblqemc) = uzesgslebu npharsyhia (uuzsgxjeti, 69.9 - 97.6)
Positive
23 Oct 2023
(dose escalation)
wutanjqvae(ptabxmrneo) = mwltunifxy peddkrzhag (bkdppvybsw )
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Biosimilar

Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Hiro LS Researcher
The AI Search Engine Built to Accelerate Biopharma Decisions
Search across billion-scale life sciences data to uncover signals, validate evidence, and act with confidence.
Ask any biopharma research question→
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, Patsnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Discover Synapse Data Servers
Synapse data is now integrated into the PatSnap LS Model Context Protocol (MCP) service. Customize your LLM agent now using our MCP server!
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free